Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

A role of indices of oxidative stress, oxidative injury, and abnormal membrane phospholipid, specifically the phospholipid essential polyunsaturated fatty acids (EPUFAs) metabolism has been suggested based on studies in separate groups of patients with or without medication. The current study invest...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Prostaglandins, leukotrienes and essential fatty acids leukotrienes and essential fatty acids, 2003-12, Vol.69 (6), p.393-399
Hauptverfasser: Evans, D.R, Parikh, V.V, Khan, M.M, Coussons, C, Buckley, P.F, Mahadik, S.P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 399
container_issue 6
container_start_page 393
container_title Prostaglandins, leukotrienes and essential fatty acids
container_volume 69
creator Evans, D.R
Parikh, V.V
Khan, M.M
Coussons, C
Buckley, P.F
Mahadik, S.P
description A role of indices of oxidative stress, oxidative injury, and abnormal membrane phospholipid, specifically the phospholipid essential polyunsaturated fatty acids (EPUFAs) metabolism has been suggested based on studies in separate groups of patients with or without medication. The current study investigated the relationship between these biochemical measures in first-episode psychotic patients ( N=16) at baseline and after 6 months of antipsychotic treatment ( N=5 each with risperidone and olanzapine) and compared them to matched normal subjects. The indices of oxidative stress included: antioxidant enzymes; superoxide dismutase, glutathione peroxidase and catalase; and the oxidative injury as the levels of plasma lipid peroxides. The key membrane EPUFA's been; linolenic acid, arachidonic acid, nervonic acid, docosapentaenoic acid and docosahexaenoic acid. Furthermore, the changes in these biochemical measures were correlated with clinical symptomatology. Data indicated that, at baseline, reduced levels of antioxidant enzymes were associated with increased plasma lipid peroxides and reduced membrane EPUFAs, particularly omega-3 fatty acids. Furthermore, these biochemical measures normalized after 6 months of antipsychotic treatment. Parallel-improved psychopathology indicated that membrane EPUFA status might be partly affected by oxidative damage, which together may contribute to the pathophysiology and thereby, psychopathology of schizophrenia. These data also support the augmentation of antipsychotic treatment by supplementation with a combination of antioxidants and omega-3 fatty acids.
doi_str_mv 10.1016/j.plefa.2003.08.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71379335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0952327803001625</els_id><sourcerecordid>71379335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-52dd6d7fdd54292e6988e0b2832fa2dbb37c55670246fecb80e019a479192e073</originalsourceid><addsrcrecordid>eNp9kDtrHDEUhYVJiNd2fkEgqEo3kytpNI8iRTDxAwwBE9dCI92xtWhWE0kbs_710XoX3LlScb9zxPkI-cKgZsDa7-t68TjpmgOIGvoaGJyQFZOCV7zn4gNZwSB5JXjXn5KzlNYAwBlrPpFT1rRcNANfkZd7tHT0IVhq0Hs64zxGvUGKKeEmO-3ppHPeUW2cLdesx-BdmqnbUNTR7-iSduYpZGfoorMrmUSn4H14dptHqkvFG2Dj9pHmiDrPhbsgHyftE34-vufk4erXn8ub6u739e3lz7vKCClzJbm1re0ma2XDB47t0PcII-8FnzS34yg6I2XbAW_aCc3YAwIbdNMNrNDQiXPy7dC7xPB3iymr2aX92DIzbJPqmOgGIWQBxQE0MaQUcVJLdLOOO8VA7ZWrtXpVrvbKFfSqKC-pr8f67TijfcscHRfgxwHAMvKfw6iSKZ4MWhfRZGWDe_eD_0f0lcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71379335</pqid></control><display><type>article</type><title>Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Evans, D.R ; Parikh, V.V ; Khan, M.M ; Coussons, C ; Buckley, P.F ; Mahadik, S.P</creator><creatorcontrib>Evans, D.R ; Parikh, V.V ; Khan, M.M ; Coussons, C ; Buckley, P.F ; Mahadik, S.P</creatorcontrib><description>A role of indices of oxidative stress, oxidative injury, and abnormal membrane phospholipid, specifically the phospholipid essential polyunsaturated fatty acids (EPUFAs) metabolism has been suggested based on studies in separate groups of patients with or without medication. The current study investigated the relationship between these biochemical measures in first-episode psychotic patients ( N=16) at baseline and after 6 months of antipsychotic treatment ( N=5 each with risperidone and olanzapine) and compared them to matched normal subjects. The indices of oxidative stress included: antioxidant enzymes; superoxide dismutase, glutathione peroxidase and catalase; and the oxidative injury as the levels of plasma lipid peroxides. The key membrane EPUFA's been; linolenic acid, arachidonic acid, nervonic acid, docosapentaenoic acid and docosahexaenoic acid. Furthermore, the changes in these biochemical measures were correlated with clinical symptomatology. Data indicated that, at baseline, reduced levels of antioxidant enzymes were associated with increased plasma lipid peroxides and reduced membrane EPUFAs, particularly omega-3 fatty acids. Furthermore, these biochemical measures normalized after 6 months of antipsychotic treatment. Parallel-improved psychopathology indicated that membrane EPUFA status might be partly affected by oxidative damage, which together may contribute to the pathophysiology and thereby, psychopathology of schizophrenia. These data also support the augmentation of antipsychotic treatment by supplementation with a combination of antioxidants and omega-3 fatty acids.</description><identifier>ISSN: 0952-3278</identifier><identifier>EISSN: 1532-2823</identifier><identifier>DOI: 10.1016/j.plefa.2003.08.010</identifier><identifier>PMID: 14623492</identifier><language>eng</language><publisher>Scotland: Elsevier Ltd</publisher><subject>Adult ; Alkanes - blood ; Antioxidants - therapeutic use ; Antipsychotic Agents - therapeutic use ; Antipsychotics ; Drug Therapy, Combination ; Erythrocyte Membrane - drug effects ; Erythrocyte Membrane - metabolism ; Erythrocytes - enzymology ; Essential fatty acids ; Fatty Acids, Essential - blood ; Fatty Acids, Omega-3 - therapeutic use ; Fatty Acids, Unsaturated - blood ; Humans ; Lipid Peroxides - blood ; Membrane phospholipids ; Oxidative Stress ; Psychotic Disorders - blood ; Schizophrenia</subject><ispartof>Prostaglandins, leukotrienes and essential fatty acids, 2003-12, Vol.69 (6), p.393-399</ispartof><rights>2003 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-52dd6d7fdd54292e6988e0b2832fa2dbb37c55670246fecb80e019a479192e073</citedby><cites>FETCH-LOGICAL-c355t-52dd6d7fdd54292e6988e0b2832fa2dbb37c55670246fecb80e019a479192e073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.plefa.2003.08.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14623492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evans, D.R</creatorcontrib><creatorcontrib>Parikh, V.V</creatorcontrib><creatorcontrib>Khan, M.M</creatorcontrib><creatorcontrib>Coussons, C</creatorcontrib><creatorcontrib>Buckley, P.F</creatorcontrib><creatorcontrib>Mahadik, S.P</creatorcontrib><title>Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment</title><title>Prostaglandins, leukotrienes and essential fatty acids</title><addtitle>Prostaglandins Leukot Essent Fatty Acids</addtitle><description>A role of indices of oxidative stress, oxidative injury, and abnormal membrane phospholipid, specifically the phospholipid essential polyunsaturated fatty acids (EPUFAs) metabolism has been suggested based on studies in separate groups of patients with or without medication. The current study investigated the relationship between these biochemical measures in first-episode psychotic patients ( N=16) at baseline and after 6 months of antipsychotic treatment ( N=5 each with risperidone and olanzapine) and compared them to matched normal subjects. The indices of oxidative stress included: antioxidant enzymes; superoxide dismutase, glutathione peroxidase and catalase; and the oxidative injury as the levels of plasma lipid peroxides. The key membrane EPUFA's been; linolenic acid, arachidonic acid, nervonic acid, docosapentaenoic acid and docosahexaenoic acid. Furthermore, the changes in these biochemical measures were correlated with clinical symptomatology. Data indicated that, at baseline, reduced levels of antioxidant enzymes were associated with increased plasma lipid peroxides and reduced membrane EPUFAs, particularly omega-3 fatty acids. Furthermore, these biochemical measures normalized after 6 months of antipsychotic treatment. Parallel-improved psychopathology indicated that membrane EPUFA status might be partly affected by oxidative damage, which together may contribute to the pathophysiology and thereby, psychopathology of schizophrenia. These data also support the augmentation of antipsychotic treatment by supplementation with a combination of antioxidants and omega-3 fatty acids.</description><subject>Adult</subject><subject>Alkanes - blood</subject><subject>Antioxidants - therapeutic use</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Antipsychotics</subject><subject>Drug Therapy, Combination</subject><subject>Erythrocyte Membrane - drug effects</subject><subject>Erythrocyte Membrane - metabolism</subject><subject>Erythrocytes - enzymology</subject><subject>Essential fatty acids</subject><subject>Fatty Acids, Essential - blood</subject><subject>Fatty Acids, Omega-3 - therapeutic use</subject><subject>Fatty Acids, Unsaturated - blood</subject><subject>Humans</subject><subject>Lipid Peroxides - blood</subject><subject>Membrane phospholipids</subject><subject>Oxidative Stress</subject><subject>Psychotic Disorders - blood</subject><subject>Schizophrenia</subject><issn>0952-3278</issn><issn>1532-2823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtrHDEUhYVJiNd2fkEgqEo3kytpNI8iRTDxAwwBE9dCI92xtWhWE0kbs_710XoX3LlScb9zxPkI-cKgZsDa7-t68TjpmgOIGvoaGJyQFZOCV7zn4gNZwSB5JXjXn5KzlNYAwBlrPpFT1rRcNANfkZd7tHT0IVhq0Hs64zxGvUGKKeEmO-3ppHPeUW2cLdesx-BdmqnbUNTR7-iSduYpZGfoorMrmUSn4H14dptHqkvFG2Dj9pHmiDrPhbsgHyftE34-vufk4erXn8ub6u739e3lz7vKCClzJbm1re0ma2XDB47t0PcII-8FnzS34yg6I2XbAW_aCc3YAwIbdNMNrNDQiXPy7dC7xPB3iymr2aX92DIzbJPqmOgGIWQBxQE0MaQUcVJLdLOOO8VA7ZWrtXpVrvbKFfSqKC-pr8f67TijfcscHRfgxwHAMvKfw6iSKZ4MWhfRZGWDe_eD_0f0lcw</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Evans, D.R</creator><creator>Parikh, V.V</creator><creator>Khan, M.M</creator><creator>Coussons, C</creator><creator>Buckley, P.F</creator><creator>Mahadik, S.P</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031201</creationdate><title>Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment</title><author>Evans, D.R ; Parikh, V.V ; Khan, M.M ; Coussons, C ; Buckley, P.F ; Mahadik, S.P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-52dd6d7fdd54292e6988e0b2832fa2dbb37c55670246fecb80e019a479192e073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Alkanes - blood</topic><topic>Antioxidants - therapeutic use</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Antipsychotics</topic><topic>Drug Therapy, Combination</topic><topic>Erythrocyte Membrane - drug effects</topic><topic>Erythrocyte Membrane - metabolism</topic><topic>Erythrocytes - enzymology</topic><topic>Essential fatty acids</topic><topic>Fatty Acids, Essential - blood</topic><topic>Fatty Acids, Omega-3 - therapeutic use</topic><topic>Fatty Acids, Unsaturated - blood</topic><topic>Humans</topic><topic>Lipid Peroxides - blood</topic><topic>Membrane phospholipids</topic><topic>Oxidative Stress</topic><topic>Psychotic Disorders - blood</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evans, D.R</creatorcontrib><creatorcontrib>Parikh, V.V</creatorcontrib><creatorcontrib>Khan, M.M</creatorcontrib><creatorcontrib>Coussons, C</creatorcontrib><creatorcontrib>Buckley, P.F</creatorcontrib><creatorcontrib>Mahadik, S.P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Prostaglandins, leukotrienes and essential fatty acids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evans, D.R</au><au>Parikh, V.V</au><au>Khan, M.M</au><au>Coussons, C</au><au>Buckley, P.F</au><au>Mahadik, S.P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment</atitle><jtitle>Prostaglandins, leukotrienes and essential fatty acids</jtitle><addtitle>Prostaglandins Leukot Essent Fatty Acids</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>69</volume><issue>6</issue><spage>393</spage><epage>399</epage><pages>393-399</pages><issn>0952-3278</issn><eissn>1532-2823</eissn><abstract>A role of indices of oxidative stress, oxidative injury, and abnormal membrane phospholipid, specifically the phospholipid essential polyunsaturated fatty acids (EPUFAs) metabolism has been suggested based on studies in separate groups of patients with or without medication. The current study investigated the relationship between these biochemical measures in first-episode psychotic patients ( N=16) at baseline and after 6 months of antipsychotic treatment ( N=5 each with risperidone and olanzapine) and compared them to matched normal subjects. The indices of oxidative stress included: antioxidant enzymes; superoxide dismutase, glutathione peroxidase and catalase; and the oxidative injury as the levels of plasma lipid peroxides. The key membrane EPUFA's been; linolenic acid, arachidonic acid, nervonic acid, docosapentaenoic acid and docosahexaenoic acid. Furthermore, the changes in these biochemical measures were correlated with clinical symptomatology. Data indicated that, at baseline, reduced levels of antioxidant enzymes were associated with increased plasma lipid peroxides and reduced membrane EPUFAs, particularly omega-3 fatty acids. Furthermore, these biochemical measures normalized after 6 months of antipsychotic treatment. Parallel-improved psychopathology indicated that membrane EPUFA status might be partly affected by oxidative damage, which together may contribute to the pathophysiology and thereby, psychopathology of schizophrenia. These data also support the augmentation of antipsychotic treatment by supplementation with a combination of antioxidants and omega-3 fatty acids.</abstract><cop>Scotland</cop><pub>Elsevier Ltd</pub><pmid>14623492</pmid><doi>10.1016/j.plefa.2003.08.010</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0952-3278
ispartof Prostaglandins, leukotrienes and essential fatty acids, 2003-12, Vol.69 (6), p.393-399
issn 0952-3278
1532-2823
language eng
recordid cdi_proquest_miscellaneous_71379335
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Alkanes - blood
Antioxidants - therapeutic use
Antipsychotic Agents - therapeutic use
Antipsychotics
Drug Therapy, Combination
Erythrocyte Membrane - drug effects
Erythrocyte Membrane - metabolism
Erythrocytes - enzymology
Essential fatty acids
Fatty Acids, Essential - blood
Fatty Acids, Omega-3 - therapeutic use
Fatty Acids, Unsaturated - blood
Humans
Lipid Peroxides - blood
Membrane phospholipids
Oxidative Stress
Psychotic Disorders - blood
Schizophrenia
title Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A43%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Red%20blood%20cell%20membrane%20essential%20fatty%20acid%20metabolism%20in%20early%20psychotic%20patients%20following%20antipsychotic%20drug%20treatment&rft.jtitle=Prostaglandins,%20leukotrienes%20and%20essential%20fatty%20acids&rft.au=Evans,%20D.R&rft.date=2003-12-01&rft.volume=69&rft.issue=6&rft.spage=393&rft.epage=399&rft.pages=393-399&rft.issn=0952-3278&rft.eissn=1532-2823&rft_id=info:doi/10.1016/j.plefa.2003.08.010&rft_dat=%3Cproquest_cross%3E71379335%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71379335&rft_id=info:pmid/14623492&rft_els_id=S0952327803001625&rfr_iscdi=true